N NexMed
NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.
About NexMed
NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.
Company Details
Social Media
Frequently Asked Questions
What does NexMed do?
NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.
How can I contact NexMed?
Visit their website at nexmed.com for more information.
Where is NexMed located?
San Diego, United States
What industry is NexMed in?
biotechnology-research
How many employees does NexMed have?
50-200
When was NexMed founded?
Founding date information is not available.
Looking for More Company Information?
Discover more innovative companies in our comprehensive directory.
Browse All Companies